Repetitive DNA-binding domain in KMT2A-PTD exhibits transcriptional potential in vitro19 and KMT2A-PTD contributes to the leukemic phenotype in KMT2A-WT AML cells via a recessive gain-of-function mechanism20. This evidence concerns the gene BCS1L and acute myeloid leukemia.